Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 2

Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST)

Total article views   Abstract views HTML views PDF downloads Totals
2,574 Dovepress* 2,574 0+ 1,326 2,574
Totals 2,574 0 1,326 2,574
*Since 15 May 2007
+Since July 2016

View citations on Google Scholar